Last reviewed · How we verify
postoperative adjuvant chemotherapy — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
postoperative adjuvant chemotherapy (postoperative adjuvant chemotherapy) — Peng Zhang.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| postoperative adjuvant chemotherapy TARGET | postoperative adjuvant chemotherapy | Peng Zhang | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- postoperative adjuvant chemotherapy CI watch — RSS
- postoperative adjuvant chemotherapy CI watch — Atom
- postoperative adjuvant chemotherapy CI watch — JSON
- postoperative adjuvant chemotherapy alone — RSS
Cite this brief
Drug Landscape (2026). postoperative adjuvant chemotherapy — Competitive Intelligence Brief. https://druglandscape.com/ci/postoperative-adjuvant-chemotherapy. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab